Interferon-β stabilizes barrier characteristics of the blood–brain barrier in four different species in vitro

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Multiple Sclerosis

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1352458508088940PMID 18505778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of Action for Treatments in Multiple Sclerosis

  2012cited by this paper
• Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass.

  2005cited by this paper
• Human interferons alpha, beta and omega.

  2004cited by this paper
• Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro.

  2004influential reference
• Interferon-β1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis

  2004cited by this paper
• Interferon‐β stabilizes barrier characteristics of brain endothelial cells in vitro

  2004cited by this paper
• Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

  2002cited by this paper
• Differential mechanisms of action of interferon-β and glatiramer acetate in MS

  2002cited by this paper
• Breakdown of Will

  2002cited by this paper
• Interferon-beta directly influences monocyte infiltration into the central nervous system.

  2002cited by this paper
• Interferon-β directly influences monocyte infiltration into the central nervous system

  2002cited by this paper
• Glucocorticoid and type 1 interferon interactions at the blood–brain barrier: relevance for drug therapies for multiple sclerosis

  2001cited by this paper
• Induction of sTNF‐R1 and sTNF‐R2 by interferon beta‐1b in correlation with clinical and MRI activity

  2001cited by this paper
• Mast cells and multiple sclerosis: a quantitative analysis

  2001cited by this paper
• Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

  2001cited by this paper
• Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro.

  2000cited by this paper
• Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b.

  1999cited by this paper
• In vitro model for evaluating drug transport across the blood-brain barrier.

  1999cited by this paper
• ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon β-1a and TNFα

  1998cited by this paper
• Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

  1998cited by this paper
• T cell interaction with ICAM‐1‐deficient endothelium in vitro: essential role for ICAM‐1 and ICAM‐2 in transendothelial migration of T cells

  1998cited by this paper
• ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta-1a and TNFalpha.

  1998cited by this paper
• Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.

  1998cited by this paper
• Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers.

  1997cited by this paper
• Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.

  1997cited by this paper
• Selective expression of adhesion molecules on human brain microvascular endothelial cells.

  1997cited by this paper
• Mechanisms of action of interferon-beta in multiple sclerosis.

  1996cited by this paper
• Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

  1996cited by this paper
• The mast cells of the multiple sclerosis brain.

  1996cited by this paper
• Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis

  1996cited by this paper
• Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis

  1996cited by this paper
• Effects of barbiturates on hypoxic cultures of brain derived microvascular endothelial cells.

  1996cited by this paper
• Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

  1996cited by this paper
• Mechanisms of action of interferon-β in multiple sclerosis

  1996cited by this paper
• Defining the clinical course of multiple sclerosis

  1996cited by this paper
• Interferon-β downregulates interferon-γ-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells

  1995cited by this paper
• Interferon beta in the cytokine network: an anti-inflammatory pathway

  1995cited by this paper
• Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis

  1995cited by this paper
• Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

  1995cited by this paper
• Interferon-beta downregulates interferon-gamma-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells.

  1995cited by this paper
• Binding characteristics of S fimbriated Escherichia coli to isolated brain microvascular endothelial cells.

  1994cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.

  1990cited by this paper
• Bovine Brain Endothelial Cells Express Tight Junctions and Monoamine Oxidase Activity in Long‐Term Culture

  1989cited by this paper
• Molecular sieving characteristics of the cultured endothelial monolayer

  1987cited by this paper
• Effect of rat andβ-human interferons on hyperacute experimental allergic encephalomyelitis in rats

  1985cited by this paper
• Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.

  1985cited by this paper
• Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures.

  1972cited by this paper

• Secretome of brain microvascular endothelial cells promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage

  2024cites this paper
• Type I/type III IFN and related factors regulate JEV infection and BBB endothelial integrity

  2023cites this paper
• Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis

  2023cites this paper
• Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective

  2023cites this paper
• IFN-β Deficiency Results in Fatal or Demyelinating Disease in C57BL/6 Mice Infected With Theiler’s Murine Encephalomyelitis Viruses

  2022cites this paper
• Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer’s disease

  2022cites this paper
• How Does the Immune System Enter the Brain?

  2022cites this paper
• FTY720 Exacerbates Blood–Brain Barrier Dysfunction Induced by IgG Derived from Patients with NMO and MOG Disease

  2021cites this paper
• Pathogenesis of tissue injury in the brain in patients with systemic lupus erythematosus

  2021cites this paper
• Secretome of endothelial progenitor cells from stroke patients promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage

  2021cites this paper
• Influenza A Virus (H1N1) Infection Induces Microglial Activation and Temporal Dysbalance in Glutamatergic Synaptic Transmission

  2021cites this paper
• The brain in SLE

  2021cites this paper
• Interactions of SARS-CoV-2 with the Blood–Brain Barrier

  2021cites this paper
• A Novel Microglia-Specific Transcriptional Signature Correlates With Behavioral Deficits in Neuropsychiatric Lupus

  2020cites this paper
• Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective.

  2020cites this paper
• Lipid-specific IgMs induce antiviral responses in the CNS: implications for progressive multifocal leukoencephalopathy in multiple sclerosis

  2020cites this paper
• The Innate Immune Response to Herpes Simplex Virus 1 Infection Is Dampened in the Newborn Brain and Can Be Modulated by Exogenous Interferon Beta To Improve Survival

  2020cites this paper
• Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

  2019cites this paper
• Transport Across the Blood-Brain Barrier.

  2018cites this paper
• Immortalized endothelial cell lines for in vitro blood-brain barrier models: A systematic review.

  2016influential citation
• The blood-brain barrier.

  2016cites this paper
• Viruses Responsible for Hemorrhagic Fevers

  2016cites this paper
• Inflammatory Mediators and the Blood-Brain Barrier

  2015cites this paper
• Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?

  2015cites this paper
• Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier

  2015cites this paper
• Current and future therapies targeting the immune system in multiple sclerosis.

  2014cites this paper
• Régulation moléculaire de la barrière hémo-encéphalique

  2014cites this paper
• New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.

  2014cites this paper
• Caractérisation neuro-immunitaire d'un modèle d'encéphalomyélite auto-immune expérimentale spontanée

  2013cites this paper
• The role of β1 integrins in a novel in vitro blood-brain barrier model during inflammation

  2013cites this paper
• Inflammatory and innate immune responses in dengue infection: protection versus disease induction.

  2013cites this paper
• Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI☆☆☆

  2013cites this paper
• Gene Therapy of Multiple Sclerosis Using Interferon β-Secreting Human Bone Marrow Mesenchymal Stem Cells

  2013cites this paper
• Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy

  2013cites this paper
• The Blood–Brain Barrier in Neuroinflammation

  2013cites this paper
• Transport and Drug Delivery through the Blood–Brain Barrier and Cerebrospinal Fluid

  2012cites this paper
• The blood–brain barrier in health and disease

  2012cites this paper
• Effects of anti-inflammatory treatments on stroke outcome in animal models

  2012cites this paper
• Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling

  2012cites this paper
• Experimental methods and transport models for drug delivery across the blood-brain barrier.

  2012cites this paper
• Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood–brain barrier in vitro

  2012cites this paper
• Disruption of central nervous system barriers in multiple sclerosis.

  2011cites this paper
• Multiple Preconditioning Paradigms Converge on Interferon Regulatory Factor-Dependent Signaling to Promote Tolerance to Ischemic Brain Injury

  2011cites this paper
• Identification of the Synthetic Cannabinoid R(+)WIN55,212-2 as a Novel Regulator of IFN Regulatory Factor 3 Activation and IFN-β Expression

  2011cites this paper
• Dengue and Soluble Mediators of the Innate Immune System

  2011cites this paper
• Toll-Like Receptor Tolerance as a Mechanism for Neuroprotection

  2010cites this paper
• Permeability of Endothelial and Astrocyte Cocultures: In Vitro Blood–Brain Barrier Models for Drug Delivery Studies

  2010cites this paper
• CNS endothelium expression of ADAM-17 and its role in multiple sclerosis pathogenesis

  2009cites this paper
• Losing your nerves? Maybe it's the antibodies

  2009cites this paper
• REVIEW In fl ammatory and Innate Immune Responses in Dengue Infection Protection versus Disease Induction

  year unknowncites this paper